Bruker Corporation
BRKR
$39.27
-$0.54-1.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.24% | -0.45% | -0.41% | 11.04% | 14.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.24% | -0.45% | -0.41% | 11.04% | 14.64% |
| Cost of Revenue | 6.11% | 1.99% | 7.40% | 11.90% | 14.50% |
| Gross Profit | -6.38% | -2.95% | -8.31% | 10.18% | 14.78% |
| SG&A Expenses | -0.73% | 5.48% | 4.56% | 15.42% | 18.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 14,575.00% | -1,220.59% | 62.07% | 143.75% | -77.78% |
| Total Operating Expenses | 9.75% | -2.60% | 6.91% | 14.17% | 16.78% |
| Operating Income | -56.50% | 16.88% | -64.79% | -13.95% | 3.94% |
| Income Before Tax | 22.71% | -231.76% | -95.36% | -64.48% | -77.41% |
| Income Tax Expenses | -7.13% | -195.27% | -119.25% | -56.06% | 9.70% |
| Earnings from Continuing Operations | 110.07% | -245.16% | -44.74% | -67.69% | -93.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1,500.00% | -283.33% | -- | 154.55% | -122.22% |
| Net Income | 89.78% | -245.72% | 0.00% | -65.82% | -93.33% |
| EBIT | -56.50% | 16.88% | -64.79% | -13.95% | 3.94% |
| EBITDA | -39.01% | 14.21% | -33.15% | 3.91% | 11.81% |
| EPS Basic | 8.41% | -252.26% | -2.91% | -67.26% | -93.60% |
| Normalized Basic EPS | -64.19% | 19.25% | -70.64% | -26.48% | 0.27% |
| EPS Diluted | 8.41% | -252.26% | 0.00% | -68.57% | -93.58% |
| Normalized Diluted EPS | -64.22% | 19.62% | -70.52% | -26.26% | 0.34% |
| Average Basic Shares Outstanding | 0.26% | 0.20% | 2.85% | 4.41% | 4.19% |
| Average Diluted Shares Outstanding | 0.33% | -0.13% | 2.50% | 4.11% | 4.11% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.22% | -1.00% | -0.01% | 2.09% | 14.62% |